Developed by the IBEC, this system is created using patient cells and represents the first 3D muscle model capable of replicating the damage caused by Duchenne muscular dystrophy. The next phase of this project involves the development of an organ-on-a-chip platform, enabling more efficient preclinical studies of potential drugs and enhanced monitoring of muscle damage. Funding for this research has been provided by Duchenne Parent Project Spain, a non-profit association led by families with children affected by this form of dystrophy.
A new study recently published in the journal Scientific Reports, and led by the Institute for Bioengineering of Catalonia (IBEC) in collaboration with MIT, sheds new information on the role … Read more
On November 15th, the World Day of Neuromuscular diseases was celebrated. Coinciding with the date, IBEC organised two events that brought together scientist and patients to talk about the new … Read more
Scientists and patients meet at the IBEC to look for new treatment strategies for these minority pathologies. The journal Ara interviewed Juanma Fernandez Costa, postdoc researcher at the group of … Read more